Tag: NEJM

DB-OTO Gene Therapy Restores Hearing in Children with Genetic Deafness – NEJM Study 2025

A new NEJM study shows that DB-OTO, a dual AAV1 gene therapy, restored natural hearing in 75% of children with otoferlin-related inherited deafness. This breakthrough could transform treatment for congenital hearing loss.